ISSN - 0973-0958

Pediatric Oncall Journal View Article

Pityriasis Rosea in Children - Cases reports and review
João Pedro Faria Dias, Ana Catarina Soares Feio de Azevedo, Clara Isabel Bessa Vieira, Hernâni Fernando da Costa Brito.
Pediatrics Department, Centro Hospitalar do Médio Ave, Vila Nova de Famalicão, Portugal.
Abstract
Pityriasis rosea (PR) is a common, self-limited skin disease that primarily affects children and adolescents. It is characterized by the appearance of an oval-shaped, scaly rash that typically begins with a single patch known as the herald patch. The exact cause of this condition is not known, but it is believed to be related to viral infections. The diagnosis is based on history and physical examination of the rash and this entity should be distinguished from several diseases, including secondary syphilis. This article reports three PR cases in children and reviews the etiology, clinical features, differential diagnosis, and management of PR in pediatric patients.
Why this article important?
Dear Editors, I embarked on this study to illuminate the clinical presentation, management, and outcomes of Pityriasis Rosea (PR) in the pediatric population. Recognizing the limited available literature, I aimed to compile comprehensive case reports and critically analyze existing research on this subject. Through an extensive review of scientific databases, clinical journals, and medical textbooks, I synthesized diverse case studies involving children diagnosed with PR. By systematically analyzing clinical presentations, diagnostic methods, treatment modalities, and long-term outcomes, I sought to consolidate knowledge and provide clinicians with a valuable resource to enhance diagnostic accuracy and improve patient care. The literature review highlights the characteristic features of PR, including the distinctive herald patch, subsequent rash patterns, and associated symptoms. Additionally, it explores challenges faced by healthcare professionals in differentiating PR from other dermatological conditions in children, such as eczema, ringworm, and guttate psoriasis. The analysis also offers insights into various treatment options, including topical corticosteroids, antihistamines, and phototherapy, along with their efficacy and potential adverse effects in pediatric patients. By presenting a comprehensive overview of PR in children, my literature review aims to serve as a valuable resource for clinicians, pediatricians, and dermatologists who encounter cases of this condition.
Summary of article
Pityriasis rosea (PR) is an acute, self-limiting papulosquamous rash frequently observed in healthy children, and it is believed to be caused by a viral infection. The condition typically begins with a single “herald patch,” a larger, oval, pink or red lesion that appears on the trunk. This is followed by the appearance of multiple smaller lesions that spread along the Langer lines, creating a characteristic Christmas tree pattern on the back. PR can be mistaken for other skin conditions, making awareness of the differential diagnosis crucial. Conditions to rule out include tinea corporis, nummular eczema, guttate psoriasis, and secondary syphilis. Diagnosis is primarily clinical, based on the appearance and distribution of the rash. Treatment is generally supportive, focusing on relieving symptoms such as itching with antihistamines or topical corticosteroids. The rash typically resolves on its own within six to eight weeks without any long-term effects.

READ FULL TEXT
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0